Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present andfuture
Terry Cheuk‐Fung Yip(Chinese University of Hong Kong), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Guanlin Li(Chinese University of Hong Kong), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Huapeng Lin(Zhejiang University), Fei Lyu(Hong Kong Baptist University), Pong C. Yuen(Hong Kong Baptist University)
Cited by 43
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777